HomeMedical SpecialtiesCardiologySt. Paul's Hospital implants next generation defibrillator

St. Paul’s Hospital implants next generation defibrillator

Published on

It delivers a life-saving shock to the heart without ever actually touching it. Doctors at St. Paul’s Hospital, in collaboration with Cardiac Services BC and a group of physicians from around the province, have taken a step towards revolutionizing the care of people with cardiac arrhythmias in British Columbia by implanting the first ever subcutaneous implantable cardioverter defibrillator (S-ICD) in BC.

“One of the biggest challenges we face with implantable defibrillators is the invasiveness of the procedure,” says Dr. Jamil Bashir, cardiac surgeon and director of the laser lead extraction program at St. Paul’s. “This new device is a paradigm shift that allows us to shock the heart without having to place a wire in the blood vessels. Because the heart and blood vessels are untouched, the potential for blood vessel injury is eliminated, the potential for system infection is reduced and the patient’s vein access is preserved for the future.”

The primary purpose of the device is to monitor the patient’s heartbeat and deliver a potentially life-saving shock that disrupts a fast heart rhythm and resets the heart. Conventional ICDs, which involve a lead being placed in the veins of the upper chest, are connected directly to the heart. This feature is required for many patients who receive an ICD, and remains the standard of care in BC. The S-ICD, on the other hand, uses electrodes placed just under the skin (in the extrathoracic space) and not in the heart, leaving the heart and veins untouched. The device delivers a shock across the chest wall with the heart positioned in between.

MORE: FIRST CANADIAN HOSPITAL TO WIN PRESTIGIOUS AWARD

Mike McLellan, a sporting goods wholesaler from Squamish, was the first patient in BC to receive a S-ICD. The 44-year old father of three has not only fully recovered from surgery, but completed a grueling, four-day, 650 kilometer bike ride just a few months after having the device implanted.

“The S-ICD will only fire if it detects that I need it,” says McLellan. “I kind of look at it like a lifejacket. It’s always listening to my heart and it can differentiate between exercise and a medical issue.”

The S-ICD provides defibrillation therapy for the treatment of life-threatening ventricular tachyarrhythmias. It is a promising new device because the absence of an intracardiac lead means the need for complicated surgeries to extract failed leads is avoided. This complication occurs in about 1 in 200 patients every year.

“To be the age that I am, relatively young for heart issues, it allows you to not be at risk for that invasive lead removal or lead extraction with traditional ICDs,” says McLellan.

MORE: KEEPING COPD PATIENT OUT OF HOSPITAL

Nearly 1,000 conventional defibrillators are implanted in patients around the province per year for protection against potentially fatal arrhythmias. In addition to the defibrillation feature of an ICD, many patients also require longer term pacing. At this time, the S-ICD is currently unable to provide this therapy but may eventually be suitable for patients with other types of heart disease.

Since the first procedure, St. Paul’s Hospital, in collaboration with Cardiac Services BC and a provincial physician review panel, has implanted 18 more S-ICDs into patients. The implant team has been led by Dr. Bashir, cardiac surgeon and director of laser lead extraction program at St. Paul’s.

 

Latest articles

An ER doctor’s experience with long COVID – “My symptoms seemed endless”

On April 2022, another COVID wave was sweeping Toronto. It was the sixth since...

Tackling the issue of unused medication waste

When patients and programs don’t use all the medication that is prescribed, it is...

Obesity a risk factor for stillbirth, especially at term

Obesity is a risk factor for stillbirth, and the risk increases as pregnancy advances...

Prolonged cough? In most cases, patience is the treatment

Coughing after a respiratory infection is common and, in most cases, will resolve with...

More like this

Prolonged cough? In most cases, patience is the treatment

Coughing after a respiratory infection is common and, in most cases, will resolve with...

A New Era in Heart Failure Management: The Promise of Digital Therapeutics

Heart failure is one of the fastest growing cardiovascular conditions in the world that...

Funding to take LHSC developed technology global

On average it takes five to seven years to diagnose a rare disease. But,...

Milk and Colorectal Cancer: what does the research say?

Colorectal cancer is the fourth most common cancer in Canada and is more common...

Surgical guidance with AI

Researchers at UHN’s Toronto General Hospital Research Institute (TGHRI) have utilized artificial intelligence (AI)...

Report outlines public health response to COVID-19 outbreaks at mink farms

A report co-authored by Fraser Health Medical Health Officer Dr. Emily Newhouse and published...